Extended-Release Naltrexone Injectable Suspension for Treatment of Alcohol Dependence in Urban Primary Care

被引：0
|
作者：
Lee, J. D. [1 ]
Grossman, E. [1 ]
DiRocco, D. [1 ]
Truncali, A. [1 ]
Rotrosen, J. [1 ]
Stevens, D. [1 ]
Gourevitch, M. N. [1 ]
机构：
[1] NYU, Sch Med, Bellevue Hosp Ctr, New York, NY 10003 USA
来源：
SUBSTANCE ABUSE | 2009年 / 30卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [31] Efficacy of Extended-Release Naltrexone in Patients with Relatively Higher Severity of Alcohol Dependence
    Pettinati, Helen M.
    Silverman, Bernard L.
    Battisti, John J.
    Forman, Robert
    Schweizer, Edward
    Gastfriend, David R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (10) : 1804 - 1811
  • [32] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [33] EXTENDED-RELEASE INJECTABLE NALTREXONE (XR-NTX) TREATMENT OF ALCOHOL DEPENDENCE: REDUCTION IN CUE-INDUCED CRAVING AND CNS ACTIVATION ON FMRI
    Lukas, S. E.
    Lowen, S.
    Penetar, D.
    Lindsey, K.
    Silverman, B.
    Gastfriend, D.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 276A - 276A
  • [34] Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX) Who Will Respond?
    Nunes, Edward V.
    Krupitsky, Evgeny
    Ling, Walter
    Zummo, Jacqueline
    Memisoglu, Asli
    Silverman, Bernard L.
    Gastfriend, David R.
    JOURNAL OF ADDICTION MEDICINE, 2015, 9 (03) : 238 - 243
  • [35] A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence
    Bisaga, Adam
    Sullivan, Maria A.
    Glass, Andrew
    Mishlen, Kaitlyn
    Carpenter, Kenneth M.
    Mariani, John J.
    Levin, Frances R.
    Nunes, Edward V.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2014, 46 (05) : 546 - 552
  • [36] Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone
    Ingrid A. Binswanger
    Jason M. Glanz
    Drug Safety, 2018, 41 : 979 - 980
  • [37] Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone
    Binswanger, Ingrid A.
    Glanz, Jason M.
    DRUG SAFETY, 2018, 41 (10) : 979 - 980
  • [38] Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
    Jackson, Heide
    Mandell, Kara
    Johnson, Kimberly
    Chatterjee, Debanjana
    Vanness, David J.
    SUBSTANCE ABUSE, 2015, 36 (02) : 226 - 231
  • [39] Extended-Release Naltrexone and Harm Reduction Counseling for Chronically Homeless People With Alcohol Dependence
    Collins, Susan E.
    Duncan, Mark H.
    Smart, Brian F.
    Saxon, Andrew J.
    Malone, Daniel K.
    Jackson, T. Ron
    Ries, Richard K.
    SUBSTANCE ABUSE, 2015, 36 (01) : 21 - 33
  • [40] Extended-release injectable naltrexone for opioid use disorder: a systematic review
    Jarvis, Brantley P.
    Holtyn, August F.
    Subramaniam, Shrinidhi
    Tompkins, D. Andrew
    Oga, Emmanuel A.
    Bigelow, George E.
    Silverman, Kenneth
    ADDICTION, 2018, 113 (07) : 1188 - 1209
12345